Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Investigating retinal toxicity of tempol in a model of isolated and perfused bovine retina.

Januschowski K, Mueller S, Dollinger R, Schnichels S, Hofmann J, Spitzer MS, Bartz-Schmidt KU, Szurman P, Thaler S.

Graefes Arch Clin Exp Ophthalmol. 2014 Jun;252(6):935-41. doi: 10.1007/s00417-014-2632-4. Epub 2014 May 2.

PMID:
24789463
2.

Investigating short-term toxicity of melphalan in a model of an isolated and superfused bovine retina.

Januschowski K, Krupp C, Mueller S, Hofmann K, Schnichels S, Hagemann U, Spitzer MS, Bartz-Schmidt KU, Aisenbrey S.

Graefes Arch Clin Exp Ophthalmol. 2016 Jan;254(1):91-6. doi: 10.1007/s00417-015-3149-1. Epub 2015 Sep 3.

PMID:
26335534
3.

Testing the biocompatibility of a glutathione-containing intra-ocular irrigation solution by using an isolated perfused bovine retina organ culture model - an alternative to animal testing.

Januschowski K, Zhour A, Lee A, Maddani R, Mueller S, Spitzer MS, Schnichels S, Schultheiss M, Doycheva D, Bartz-Schmidt KU, Szurman P.

Altern Lab Anim. 2012 Mar;40(1):23-32.

PMID:
22558975
4.

The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina.

Lüke M, Januschowski K, Beutel J, Warga M, Grisanti S, Peters S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P.

Exp Eye Res. 2008 Jul;87(1):22-9. doi: 10.1016/j.exer.2008.04.005. Epub 2008 Apr 23.

PMID:
18514644
5.

Comparing the effects of two different irrigation solutions on an isolated perfused vertebrate retina.

Januschowski K, Maddani R, Mueller S, Lueke M, Spitzer MS, Schultheiss M, Bartz-Schmidt KU, Szurman P.

Ophthalmic Res. 2012;48(2):59-66. doi: 10.1159/000335365.

6.

The safety profile of alkylphosphocholines in the model of the isolated perfused vertebrate retina.

Lüke M, Januschowski K, Lüke J, Grisanti S, Szurman P, Dietz K, Kampik A, Bartz-Schmidt KU, Eibl-Lindner KH.

Graefes Arch Clin Exp Ophthalmol. 2010 Apr;248(4):511-8. doi: 10.1007/s00417-009-1246-8. Epub 2009 Dec 20.

PMID:
20091176
7.

Tempol protects against intravitreous indocyanine green-induced retinal damage in rats.

Thaler S, Voykov B, Willmann G, Fiedorowicz M, Rejdak R, Gekeler F, May CA, Schatz A, Schuettauf F.

Graefes Arch Clin Exp Ophthalmol. 2012 Nov;250(11):1597-606. doi: 10.1007/s00417-012-2000-1. Epub 2012 Mar 31.

PMID:
22460632
8.

The effects of the intraocular dye brilliant blue G (BBG) mixed with varying concentrations of glucose on retinal function in an isolated perfused vertebrate retina.

Januschowski K, Mueller S, Spitzer MS, Lueke M, Bartz-Schmidt KU, Szurman P.

Graefes Arch Clin Exp Ophthalmol. 2011 Apr;249(4):483-9. doi: 10.1007/s00417-010-1508-5. Epub 2010 Sep 19.

PMID:
20853117
9.

The effects of the phosphodiesterase type V inhibitor sildenafil on human and bovine retinal function in vitro.

Lüke M, Szurman P, Schneider T, Lüke C.

Graefes Arch Clin Exp Ophthalmol. 2007 Aug;245(8):1211-5.

PMID:
17345091
10.

Electrophysiological toxicity testing of VEGF Trap-Eye in an isolated perfused vertebrate retina organ culture model.

Januschowski K, Schnichels S, Hagemann U, Koch V, Hofmann J, Spitzer MS, Bartz-Schmidt KU, Szurman P, Lüke M, Aisenbrey S.

Acta Ophthalmol. 2014 Jun;92(4):e305-11. doi: 10.1111/aos.12300. Epub 2013 Nov 8.

11.

Effects of bevacizumab (Avastin®) on the electroretinogram of isolated rat retina.

Cia D, Cluzel J, Jacquemot N, Doly M.

Ophthalmic Res. 2011;46(3):145-51. doi: 10.1159/000324136. Epub 2011 Mar 4.

PMID:
21372616
12.

Effects of protein tyrosine kinase inhibitor genistein on retinal function in superfused vertebrate retina.

Lüke C, Krott R, Lüke M, Lebek J, Walter P, Brunner R, Sickel W.

J Ocul Pharmacol Ther. 2001 Apr;17(2):151-8.

PMID:
11324982
13.

Effects of the protein tyrosine kinase inhibitor genistein and taurine on retinal function in isolated superfused retina.

Lüke M, Krott R, Warga M, Szurman P, Grisanti S, Bartz-Schmidt KU, Schneider T, Lüke C.

Graefes Arch Clin Exp Ophthalmol. 2007 Feb;245(2):242-8.

PMID:
16453129
14.

Electrophysiological effects of Brilliant Blue G in the model of the isolated perfused vertebrate retina.

Lüke M, Januschowski K, Beutel J, Lüke C, Grisanti S, Peters S, Jaissle GB, Bartz-Schmidt KU, Szurman P.

Graefes Arch Clin Exp Ophthalmol. 2008 Jun;246(6):817-22. doi: 10.1007/s00417-007-0761-8. Epub 2008 Jan 16.

PMID:
18197412
15.

The concentration-dependent effects of indocyanine green on retinal function in the electrophysiological ex vivo model of isolated perfused vertebrate retina.

Ranjbar M, Alt A, Nassar K, Reinsberg M, Schneider T, Grisanti S, Lüke J, Lüke M.

Ophthalmic Res. 2014;51(3):167-71. doi: 10.1159/000357284. Epub 2014 Mar 13.

PMID:
24642512
16.

The effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retina.

Lüke M, Januschowski K, Lüke J, Peters S, Wirtz N, Yörük E, Lüke C, Bartz-Schmidt KU, Grisanti S, Szurman P.

Br J Ophthalmol. 2009 Oct;93(10):1396-400. doi: 10.1136/bjo.2009.157511. Epub 2009 Jul 23.

PMID:
19628500
17.

Investigating the biocompatibility of two new heavy intraocular dyes for vitreoretinal surgery with an isolated perfused vertebrate retina organ culture model and a retinal ganglion cell line.

Januschowski K, Mueller S, Spitzer MS, Hoffmann J, Schramm C, Schultheiss M, Bartz-Schmidt KU, Szurman P.

Graefes Arch Clin Exp Ophthalmol. 2012 Apr;250(4):533-45. doi: 10.1007/s00417-011-1895-2. Epub 2011 Dec 16.

PMID:
22173218
18.

Effects of phosphodiesterase type 5 inhibitor sildenafil on retinal function in isolated superfused retina.

Lüke M, Lüke C, Hescheler J, Schneider T, Sickel W.

J Ocul Pharmacol Ther. 2005 Aug;21(4):305-14.

PMID:
16117694
19.

Effects of daunorubicin and CD95L on retinal function in superfused vertebrate retina.

Hueber A, Lüke M, Esser PJ, Kirchhof B, Sickel W, Lüke C.

J Ocul Pharmacol Ther. 2005 Apr;21(2):133-8.

PMID:
15857279
20.

Effects of bevacizumab on retinal function in isolated vertebrate retina.

Lüke M, Warga M, Ziemssen F, Gelisken F, Grisanti S, Schneider T, Lüke C, Partsch M, Bartz-Schmidt KU, Szurman P; Tuebingen Bevacizumab Study Group..

Br J Ophthalmol. 2006 Sep;90(9):1178-82. Epub 2006 Jun 5.

Supplemental Content

Support Center